Audrey G\u00e9rard has received \u00a3 1.5 million in funding from CRUK for a new research project to unravel the coevolving cancer and immune landscape.
A team at NDORMS has developed a new approach to significantly improve the accuracy of RNA sequencing. They pinpoint the primary source of inaccurate quantification in both short and long-read RNA sequencing, and have introduced the concept of \u201cmajority vote\u201d error correction leading to a substantial improvement in RNA molecular counting.
A training course on Principles of Management for Delayed Presenting Clubfoot (DPC) took place 11-12th December 2023 at CURE Children\u2019s Hospital of Ethiopia, Addis Ababa.
Published in PLOS, the new guideline will help the scientific community to write complete and transparent research reports involving consensus methods.
NDORMS welcomed a delegation of medical researchers from Taipei Medical University this week to exchange research ideas and for potential future collaborations.
The Oxford Experimental Medicine Clinical Research Facility (EMCRF) at NDORMS has received its first volunteers as part of the LEGACY03 trial to improve vaccine design for different age groups.
A DPhil candidate at NDORMS, Caroline received the MRC Clinical Research Training Fellowship that has enabled her to further her research into head and neck cancer.
A major clinical trial, led by the University of Nottigham and managed by the Oxford Clinical trials Research Unit (OCTRU), has shown that people with inflammatory conditions are able to improve the antibody response from a COVID-19 booster vaccination by interrupting their treatment for two weeks immediately after having the vaccine.
Four researchers at NDORMS have been awarded a Research Ignition Award, as part of an initiative by the Kennedy Trust for Rheumatology to stimulate new and ambitious avenues of research.
Two professorships in translational medicine have been endowed at the Kennedy Institute of Rheumatology thanks to a generous gift from the Kennedy Trust for Rheumatology Research.
A DPhil candidate at NDORMS, Tom Hosack received the MRC Clinical Research Training Fellowship to further his research into tissue tropism in PD-1 therapy in immune-mediated inflammatory diseases.
A recent publication from Audrey G\u00e9rard\u2019s lab looks at how a specific protein, called IFN\u03b3, can coordinate CD8+ T cell responses during a flu infection.
The annual Oxford Myeloma Workshop brings together experts in myeloma research, clinical care, patient advocates and industry representatives, to help international efforts to improve patient lives affected by multiple myeloma. Multiple myeloma is the second most common among all blood cancers, is currently incurable and puts massive strains on patient quality of life with a significantly higher proportion (10 fold) share in health care costs.
As demand for shoulder replacement surgery grows, a new study finds that up to 1 in 6 patients are having to travel to a different region for surgery, and exposes a year on year increase in the risk of serious adverse events after surgery that require admission to hospital.
The NHS ADOPT study has now begun to automatically identify patients with vertebral fracture, by using Nanox.AI an Artificial Intelligence (AI) programme to review thousands of hospital computed tomography (CT) scans. The patients are now being fast-tracked for bone health assessment by an NHS osteoporosis team.
The Oxford Translational Myeloma Centre (OTMC) will be a collective force of research, outreach and patient care that will transform treatment opportunities for multiple myeloma cancer patients.
Congratulations to Daniele Cotton winner of St Edmund Hall\u2019s graduate research journal prize for his article \u2018Jailbreak \u2013 Preventing Metastatic Cancer.\u2019
![\"Audrey](\"https://www.ndorms.ox.ac.uk/news/cruk-funding-success-for-audrey-gerard/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n